0.00Open0.00Pre Close0 Volume0 Open Interest63.00Strike Price0.00Turnover122.52%IV-22.14%PremiumDec 6, 2024Expiry Date17.91Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9929Delta0.0023Gamma4.51Leverage Ratio-0.0257Theta0.0045Rho4.48Eff Leverage0.0014Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet